Interim analysis of safety and efficacy of ruxolitinib in patients with myelofibrosis and low platelet counts
Authors:
- Moshe TalpazMTMoshe Talpaz
- Ronald PaquetteRPRonald Paquette
- Lawrence AfrinLALawrence Afrin
- Solomon I HamburgSHSolomon I Hamburg
- Josef T PrchalJPJosef T Prchal
- Katarzyna JamiesonKJKatarzyna Jamieson
- Howard R TerebeloHTHoward R Terebelo
- Gregory L OrtegaGOGregory L Ortega
- Roger M LyonsRLRoger M Lyons
- Ramon V TiuRTRamon V Tiu
- Elliott F WintonEWElliott F Winton
- Kavita NatrajanKNKavita Natrajan
Open Access
- 29 October 2013
- journal article
- research article
- Published by Springer Nature in Journal of Hematology & Oncology
- Vol. 6 (1) , 81
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Management of cytopenias in patients with myelofibrosis treated with ruxolitinib and effect of dose modifications on efficacy outcomesOncoTargets and Therapy, 2013
- Effect of Ruxolitinib Therapy on Myelofibrosis-Related Symptoms and Other Patient-Reported Outcomes in COMFORT-I: A Randomized, Double-Blind, Placebo-Controlled TrialJournal of Clinical Oncology, 2013
- Profile of cabozantinib and its potential in the treatment of advanced medullary thyroid cancerOncoTargets and Therapy, 2013
- One Thousand Patients With Primary Myelofibrosis: The Mayo Clinic ExperienceMayo Clinic Proceedings, 2012
- In Vitro Megakaryocyte Differentiation and Proplatelet Formation in Ph-Negative Classical Myeloproliferative Neoplasms: Distinct Patterns in the Different Clinical PhenotypesPLOS ONE, 2011
- Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasmsBlood, 2010
- How I treat symptomatic splenomegaly in patients with myelofibrosisBlood, 2009
- New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and TreatmentBlood, 2009
- JAKs in pathology: Role of Janus kinases in hematopoietic malignancies and immunodeficienciesSeminars in Cell & Developmental Biology, 2008
- Myelofibrosis with Myeloid MetaplasiaNew England Journal of Medicine, 2000